One Global Service Provider has announced its 34th AGM, proposing a Re 1 dividend alongside a major Rs 500 crore related party transaction with Lifenity Health. The company, which saw FY26 profit surge to Rs 69.50 crore, is also acquiring a 51% stake in two Matrix Labs entities. To support these expansion plans, the firm seeks to double its authorized share capital to Rs 50 crore. Shareholders will vote on these proposals on September 29, 2026.
One Global Service Provider Announces Major Expansion and FY26 Growth
Profit rose to Rs 69.50 crore in FY26 from Rs 18.47 crore in FY25; Revenue jumped to Rs 498.81 crore.
Reader Takeaway: Strong inorganic growth through acquisitions balanced by large-scale related party transaction dependencies and capital restructuring requirements.
What just happened
One Global Service Provider Ltd has scheduled its 34th Annual General Meeting for September 29, 2026. The company is seeking shareholder approval for a final dividend of Re 1 per share. Key agenda items include acquiring a 51% controlling stake in Matrix Labs Diagnocare Private Limited and Matrix Labs Private Limited for Rs 43.11 crore via a preferential share issue at Rs 553 per share.
Why this matters
The company is scaling rapidly following the amalgamation of Plus Care Internationals. The board has proposed an increase in authorized share capital from Rs 25.05 crore to Rs 50 crore to facilitate this expansion. Additionally, a massive Rs 500 crore material related party transaction with Lifenity Health Limited is up for approval, signaling a strategic shift in operational scale.
The backstory
FY26 proved to be a transformational year for the company. Revenue soared to Rs 498.81 crore compared to Rs 147.84 crore in the previous fiscal year. This growth is primarily linked to the integration of Plus Care Internationals. The firm now plans to consolidate its position in the diagnostic and health services sector through the new Matrix Labs acquisitions.
Risks to watch
Investors should monitor the execution risks associated with integrating the newly acquired labs. Furthermore, the Rs 500 crore transaction with Lifenity Health Limited represents a significant concentration of business with a single related party. Shareholders should assess the arm's length nature of these dealings to ensure governance transparency.
Context metrics
- Net Worth: Rs 141.23 crore as of FY26.
- Auditor: Re-appointment of M/s. S D P M & Co. for a 5-year term.
What to track next
Watch for shareholder voting outcomes during the AGM on September 29 and any follow-up disclosures regarding the actual deployment of the Rs 500 crore capital allocated for Lifenity Health transactions.